Literature DB >> 32789500

An Inactivated Virus Candidate Vaccine to Prevent COVID-19.

Mark J Mulligan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32789500     DOI： 10.1001/jama.2020.15539

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques.

Authors:  Yuzhong Li; Yanwei Bi; Hongjian Xiao; Yueting Yao; Xiaojuan Liu; Zhengrong Hu; Jinmei Duan; Yaoyun Yang; Zhihua Li; Yadong Li; Heng Zhang; Chen Ding; Jianbo Yang; Haiwei Li; Zhanlong He; Longding Liu; Guangnan Hu; Shuying Liu; Yanchun Che; Shixia Wang; Qihan Li; Shan Lu; Wei Cun
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

2.  Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques.

Authors:  Kevin R Bewley; Karen Gooch; Kelly M Thomas; Stephanie Longet; Nathan Wiblin; Laura Hunter; Kin Chan; Phillip Brown; Rebecca A Russell; Catherine Ho; Gillian Slack; Holly E Humphries; Leonie Alden; Lauren Allen; Marilyn Aram; Natalie Baker; Emily Brunt; Rebecca Cobb; Susan Fotheringham; Debbie Harris; Chelsea Kennard; Stephanie Leung; Kathryn Ryan; Howard Tolley; Nadina Wand; Andrew White; Laura Sibley; Charlotte Sarfas; Geoff Pearson; Emma Rayner; Xiaochao Xue; Teresa Lambe; Sue Charlton; Sarah Gilbert; Quentin J Sattentau; Fergus Gleeson; Yper Hall; Simon Funnell; Sally Sharpe; Francisco J Salguero; Andrew Gorringe; Miles Carroll
Journal:  Sci Adv       Date:  2021-09-10       Impact factor: 14.136

Review 3.  Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Authors:  Jitendra Kumar Chaudhary; Rohitash Yadav; Pankaj Kumar Chaudhary; Anurag Maurya; Nimita Kant; Osamah Al Rugaie; Hoineiting Rebecca Haokip; Deepika Yadav; Rakesh Roshan; Ramasare Prasad; Apurva Chatrath; Dharmendra Singh; Neeraj Jain; Puneet Dhamija
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

Review 4.  Vaccines platforms and COVID-19: what you need to know.

Authors:  Isabel Acosta-Coley; Leonor Cervantes-Ceballos; Lesly Tejeda-Benítez; Lucellys Sierra-Márquez; María Cabarcas-Montalvo; María García-Espiñeira; Wilfrido Coronell-Rodríguez; Bárbara Arroyo-Salgado
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-08-15

5.  Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges.

Authors:  Tangchun Wu
Journal:  Front Med       Date:  2020-10-24       Impact factor: 9.927
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.